Replies to post #67476 on NanoViricides Inc. (NNVC)

[JG36]

So H7N9 is now an "immediate problem". That would be relevant had NNVC met its original time tables, because right now it would have a treatment to sell. There are real human consequences of NNVC's long sad history of missed deadlines. But how does H7N9 make the construction of the manufacturing facility go faster? How does it speed up the tox testing? No human trials are going to be done until both of those items are completed, no matter how "immediate" the problem of H7N9 might be.

[SuperSquirrel]

FluCude was in the running for priority development. H7N9 is Tamiflu resistant.

Interesting.

[velvetpolecat]

:)